Thomas S. Mir

2.5k total citations
67 papers, 1.7k citations indexed

About

Thomas S. Mir is a scholar working on Cardiology and Cardiovascular Medicine, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Thomas S. Mir has authored 67 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Cardiology and Cardiovascular Medicine, 28 papers in Genetics and 25 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Thomas S. Mir's work include Connective tissue disorders research (27 papers), Cardiac Valve Diseases and Treatments (23 papers) and Aortic Disease and Treatment Approaches (17 papers). Thomas S. Mir is often cited by papers focused on Connective tissue disorders research (27 papers), Cardiac Valve Diseases and Treatments (23 papers) and Aortic Disease and Treatment Approaches (17 papers). Thomas S. Mir collaborates with scholars based in Germany, United States and Belgium. Thomas S. Mir's co-authors include Stephanie Läer, Jochen Weil, Yskert Von Kodolitsch, Jan Falkenberg, Stefanie Albers, Bernd Meibohm, Amiram Nir, Meike Rybczynski, Benjamin Bar‐Oz and Manfred Rauh and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Thomas S. Mir

62 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas S. Mir Germany 23 1.0k 729 552 400 387 67 1.7k
Jochen Weil Germany 19 933 0.9× 332 0.5× 448 0.8× 69 0.2× 213 0.6× 41 1.4k
Sanjeev Aggarwal United States 27 1.2k 1.1× 862 1.2× 931 1.7× 47 0.1× 708 1.8× 157 2.2k
Geraldine C. Derby United States 24 721 0.7× 423 0.6× 179 0.3× 82 0.2× 647 1.7× 33 2.0k
Matthias Gorenflo Germany 20 812 0.8× 985 1.4× 732 1.3× 28 0.1× 434 1.1× 109 1.6k
Paul T. Pitlick United States 16 358 0.4× 820 1.1× 633 1.1× 70 0.2× 704 1.8× 26 1.6k
Gian M. Novaro United States 20 1.3k 1.3× 515 0.7× 550 1.0× 35 0.1× 372 1.0× 51 1.7k
Alberto M. Marra Italy 26 1.1k 1.1× 839 1.2× 157 0.3× 139 0.3× 152 0.4× 112 1.9k
Jochen D. Muehlschlegel United States 24 983 1.0× 351 0.5× 303 0.5× 59 0.1× 386 1.0× 97 1.6k
Kofo O. Ogunyankin United States 12 1.5k 1.5× 398 0.5× 282 0.5× 42 0.1× 332 0.9× 26 2.0k

Countries citing papers authored by Thomas S. Mir

Since Specialization
Citations

This map shows the geographic impact of Thomas S. Mir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas S. Mir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas S. Mir more than expected).

Fields of papers citing papers by Thomas S. Mir

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas S. Mir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas S. Mir. The network helps show where Thomas S. Mir may publish in the future.

Co-authorship network of co-authors of Thomas S. Mir

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas S. Mir. A scholar is included among the top collaborators of Thomas S. Mir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas S. Mir. Thomas S. Mir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lassen, Annmarie Touborg, Yulia Artemenko, Michael Jerosch‐Herold, et al.. (2025). Initial outcomes of novel guideline-directed pharmacotherapy for systemic right heart failure in adults with congenital heart disease. Cardiovascular Diagnosis and Therapy. 15(2). 336–349.
2.
Mir, Thomas S., Gerhard Schön, Kerstin Kutsche, et al.. (2024). Late diagnosis of Marfan syndrome is associated with unplanned aortic surgery and cardiovascular death. Journal of Thoracic and Cardiovascular Surgery. 169(4). 1201–1209.e33.
3.
Kozlik‐Feldmann, Rainer, et al.. (2024). Intrinsic cardiomyopathy in pediatric Marfan syndrome: predictive factors and risk assessments. Pediatric Research. 98(4). 1467–1473.
4.
Mosquera, Laura Muiño, Elena Cervi, Katya De Groote, et al.. (2024). Management of aortic disease in children with FBN1-related Marfan syndrome. European Heart Journal. 45(39). 4156–4169. 4 indexed citations
5.
Diaz‐Gil, Daniel, Yskert Von Kodolitsch, Rainer Kozlik‐Feldmann, et al.. (2024). TGFβ level in healthy and children with Marfan syndrome—effective reduction under sartan therapy. Frontiers in Pediatrics. 12. 1276215–1276215. 1 indexed citations
6.
Szöcs, Katalin, Christoph Sinning, Peter Bannas, et al.. (2020). Marfan Syndrome Versus Bicuspid Aortic Valve Disease: Comparative Analysis of Obstetric Outcome and Pregnancy-Associated Immediate and Long-Term Aortic Complications. Journal of Clinical Medicine. 9(4). 1124–1124. 5 indexed citations
7.
Stangenberg, Martin, et al.. (2018). Rescue Nuss procedure for inferior vena cava compression syndrome following posterior scoliosis surgery in Marfan syndrome. European Spine Journal. 28(S2). 31–36. 8 indexed citations
8.
Schulz, Esther, Hansjörg Schäfer, Wolfgang Saeger, et al.. (2018). Case Report: Neonatal McCune-Albright Syndrome with Juvenile Ovarian Granulosa Cell Tumor in a 4 Months Old Girl.
9.
Müller, Götz, Christoph Sinning, Thomas S. Mir, et al.. (2018). “Tailored” endovascular pulmonary valve and root replacement for rupture of a dilated homograft. Cardiovascular Diagnosis and Therapy. 8(6). 820–824.
10.
11.
Biermann, Daniel, Alexandra Eder, Hermann Reichenspurner, et al.. (2016). Towards a Tissue-Engineered Contractile Fontan-Conduit: The Fate of Cardiac Myocytes in the Subpulmonary Circulation. PLoS ONE. 11(11). e0166963–e0166963. 12 indexed citations
12.
Blohm, Martin, W. Diehl, Tanja Zeller, et al.. (2016). Cardiovascular biomarkers in paired maternal and umbilical cord blood samples at term and near term delivery. Early Human Development. 94. 7–12. 11 indexed citations
13.
Backer, Julie De, Kerstin Kutsche, Laura Muiño Mosquera, et al.. (2016). Mitral valve prolapse syndrome and MASS phenotype: Stability of aortic dilatation but progression of mitral valve prolapse. IJC Heart & Vasculature. 10. 39–46. 9 indexed citations
14.
Sheikhzadeh, Sara, Julie De Backer, Meike Rybczynski, et al.. (2014). The main pulmonary artery in adults: a controlled multicenter study with assessment of echocardiographic reference values, and the frequency of dilatation and aneurysm in Marfan syndrome. Orphanet Journal of Rare Diseases. 9(1). 203–203. 27 indexed citations
15.
Fournier, Anne, Linda Spigelblatt, Claire Saint‐Cyr, et al.. (2012). Value of amino‐terminal pro B‐natriuretic peptide in diagnosing Kawasaki disease. Pediatrics International. 54(5). 627–633. 29 indexed citations
16.
Mortensen, Kai, Meral Aydın, Meike Rybczynski, et al.. (2009). Augmentation Index Relates to Progression of Aortic Disease in Adults With Marfan Syndrome. American Journal of Hypertension. 22(9). 971–979. 32 indexed citations
17.
Rybczynski, Meike, A. Bernhardt, U. Rehder, et al.. (2008). The spectrum of syndromes and manifestations in individuals screened for suspected Marfan syndrome. American Journal of Medical Genetics Part A. 146A(24). 3157–3166. 65 indexed citations
18.
19.
Mir, Thomas S., et al.. (2005). Levels of brain natriuretic peptide in children with right ventricular overload due to congenital cardiac disease. Cardiology in the Young. 15(4). 396–401. 37 indexed citations
20.
Mir, Thomas S., et al.. (2004). Effect of Carvedilol on QT Duration in Paediatric Patients with Congestive Heart Failure. Clinical Drug Investigation. 24(1). 9–15. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jochen Weil Breakdown of academic impact, for papers by Sanjeev Aggarwal Breakdown of academic impact, for papers by Geraldine C. Derby Breakdown of academic impact, for papers by Matthias Gorenflo Breakdown of academic impact, for papers by Paul T. Pitlick Breakdown of academic impact, for papers by Gian M. Novaro Breakdown of academic impact, for papers by Alberto M. Marra Breakdown of academic impact, for papers by Jochen D. Muehlschlegel Breakdown of academic impact, for papers by Kofo O. Ogunyankin
Rankless by CCL
2026